Evidence map›Paper›PMID 38036293›Full record

ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2023

Efficacy and safety of pulmonary vein isolation with pulsed field ablation vs. novel cryoballoon ablation system for atrial fibrillation.

Patrick Badertscher, Simon Weidlich, Sven Knecht, Niklas Stauffer, Philipp Krisai, Gian Voellmin, Stefan Osswald, Christian Sticherling, Michael Kühne

Open access · hybridAbstract read
In one paragraph

Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 5 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 5 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Using computed tomography atrial myocardial thickness maps in cryoballoon pulmonary vein isolation: the UTMOST AF II randomized clinical trial.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Anterior mitral isthmus line using pulsed-field ablation with the pentaspline catheter or radiofrequency ablation: procedural characteristics, safety, and mid-term outcomes.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  15. Article
  16. Comparative analysis of newest-generation variable-diameter cryoballoon with pulsed-field ablation for the treatment of atrial fibrillation: the CRYO-PULSE Study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Patrick BadertscherDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.ORCID 0000-0001-9751-0557
Simon WeidlichDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.ORCID 0000-0002-9160-8331
Sven KnechtDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.ORCID 0000-0001-7122-021X
Niklas StaufferDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.ORCID 0009-0005-3920-8989
Philipp KrisaiDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.ORCID 0000-0002-4367-2363
Gian VoellminDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.ORCID 0000-0002-3778-1192
Stefan OsswaldDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.ORCID 0000-0002-9240-6731
Christian SticherlingDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.ORCID 0000-0001-8428-7050
Michael KühneDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.ORCID 0000-0002-2937-3711
University Hospital of Basel · CH

Funding

Swiss Heart Foundation
6 · The paper itself

Abstract

aimsPulsed-field ablation (PFA) has emerged as a novel treatment technology for patients with atrial fibrillation (AF). Cryoballoon (CB) is the most frequently used single shot technology. A direct comparison to a novel CB system is lacking. We aimed to compare pulmonary vein isolation (PVI) using PFA vs. a novel CB system regarding efficiency, safety, myocardial injury, and outcomes. METHODS AND

resultsOne hundred and eighty-one consecutive patients underwent PVI and were included (age 64 ± 9.7 years, ejection fraction 0.58 ± 0.09, left atrial size 40 ± 6.4 mm, paroxysmal AF 64%). 106 patients (59%) underwent PFA (FARAPULSE, Boston Scientific) and 75 patients (41%) underwent CB ablation (PolarX, Boston Scientific). The median procedure time, left atrial dwell time and fluoroscopic time were similar between the PFA and the CB group with 55 [interquartile range (IQR) 43-64] min vs. 58 (IQR 48-69) min (P < 0.087), 38 (30-49) min vs. 37 (31-48) min, (P = 0.871), and 11 (IQR 9.3-14) min vs. 11 (IQR 8.7-16) min, (P < 0.81), respectively. Three procedural complications were observed in the PFA group (two tamponades, one temporary ST elevation) and three complications in the CB group (3× reversible phrenic nerve palsies). During the median follow-up of 404 days (IQR 208-560), AF recurrence was similar in the PFA group and the CB group with 24 vs. 30%, P = 0.406.

conclusionProcedural characteristics were very similar between PFA and CB in regard to procedure duration fluoroscopy time and complications. Atrial fibrillation free survival did not differ between the PFA and CB groups.

Indexed as

Atrial FibrillationCatheter AblationCryosurgeryPulmonary VeinsAgedHumansMiddle AgedRecurrenceTreatment OutcomeAtrial fibrillationCryoballoonPulmonary vein isolationPulsed field ablation

Identifiers

PMID38036293
PMCPMC10751845
OpenAlexW4389209743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.